Edge Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$1.9 |
Market Cap |
$25.62 M |
Shares Outstanding |
31.25 M |
Public Float |
21.22 M |
Address |
300 Connell Drive Berkeley Heights New Jersey 07922 United States |
Employees | - |
Website | http://www.edgetherapeutics.com |
Updated | 09/14/2018 |
Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. |